Towercrest Capital Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$302K Hold
10,599
– – 0.04% 84
2026
Q2
$255K Buy
+10,599
New +$277K 0.04% 95
2025
Q1
– Sell
-15,107
Closed -$401K – 98
2024
Q4
$401K Hold
15,107
– – 0.06% 77
2024
Q3
$437K Hold
15,107
– – 0.07% 76
2024
Q2
$423K Buy
15,107
+100
+0.7% +$2.75K 0.07% 79
2024
Q1
$416K Buy
15,007
+1,689
+13% +$46.9K 0.07% 79
2023
Q4
$383K Buy
13,318
+2,382
+22% +$72K 0.07% 80
2023
Q3
$363K Buy
10,936
+270
+3% +$9.5K 0.07% 80
2023
Q2
$391K Buy
10,666
+3,925
+58% +$153K 0.07% 75
2023
Q1
$275K Sell
6,741
-500
-7% -$21.6K 0.06% 81
2022
Q4
$371K Hold
7,241
– – 0.08% 67
2022
Q3
$317K Buy
7,241
+25
+0.3% +$1.22K 0.07% 69
2022
Q2
$378K Hold
7,216
– – 0.08% 64
2022
Q1
$374K Buy
7,216
+400
+6% +$20.8K 0.07% 70
2021
Q4
$403K Sell
6,816
-51
-0.7% -$2.53K 0.07% 67
2021
Q3
$295K Sell
6,867
-79
-1% -$3.5K 0.06% 75
2021
Q2
$272K Sell
6,946
-166
-2% -$6.46K 0.05% 77
2021
Q1
$258K Sell
7,112
-834
-10% -$29.6K 0.06% 77
2020
Q4
$293K Buy
7,946
+647
+9% +$23.7K 0.07% 72
2020
Q3
$254K Buy
7,299
+280
+4% +$9.8K 0.06% 71
2020
Q2
$218K Hold
7,019
– – 0.06% 75
2020
Q1
$217K Sell
7,019
-402
-5% -$13.7K 0.07% 73
2019
Q4
$276K Buy
7,421
+124
+2% +$4.42K 0.07% 71
2019
Q3
$249K Hold
7,297
– – 0.07% 65
2019
Q2
$299K Buy
7,297
+432
+6% +$17.2K 0.08% 61
2019
Q1
$276K Buy
6,865
+212
+3% +$8.49K 0.08% 59
2018
Q4
$276K Buy
6,653
+27
+0.4% +$1.12K 0.09% 59
2018
Q3
$277K Buy
+6,626
New +$255K 0.08% 64

Other funds holding PFE

Towercrest Capital Management's PFE Position: Q3 2026 in Review

Towercrest Capital Management held its Pfizer (PFE) position steady in Q3 2026 at 10,599 shares worth $302K. The position accounts for 0.04% of the portfolio, ranked #84.

Towercrest Capital Management first reported a position in PFE in Q3 2018 and has held it in 28 quarters since. The position peaked at $437K in Q3 2024. 2,899 funds tracked by Wall St. Rank hold PFE as of Q3 2026.

  • Towercrest Capital Management held 10,599 shares of Pfizer worth $302K as of Q3 2026.
  • Towercrest Capital Management left its Pfizer share count unchanged in Q3 2026.
  • Pfizer made up 0.04% of Towercrest Capital Management's portfolio in Q3 2026, its #84 holding.
  • Towercrest Capital Management first reported a position in Pfizer in Q3 2018 and has held it in 28 quarters since.
  • Towercrest Capital Management's Pfizer position peaked at $437K in Q3 2024.
  • 2,899 funds tracked by Wall St. Rank held Pfizer as of Q3 2026.

Based on Towercrest Capital Management's 13F filing for Q3 2026, filed 23 Oct 2026.